Clinical Trial Update: Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 2, Phase 3]

View source ↗

Summary

A trial update on lenalidomide for Diffuse Large B-Cell Lymphoma reporting completed phases 2 and 3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Diffuse Large B-cell Lymphoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-08-20